In a separate study (Valks and Burch, 2001), a search of published literature was carried out and these data were combined with Novartis’ own internal reports. A total of 20 references were compiled. Reports from 1975-1989 and from 1990-2000 were compared. The ranges of MICs of various antimicrobials against the four major mycoplasma species were entered into a database. The maximum and minimum data for each time period were compared for tiamulin, tylosin, oxytetracycline, lincomycin and enrofloxacin.
From the 20 references and reports, 13 were from before 1990 and seven from 1990 and after. There was information on 241 isolates of MG, 105 of MS, 28 of M. meleagridis (MM) and 111 of
M. iowae (MI). The comparative data for the four mycoplasma species are summarized in the tables below.
| Mycoplasma gallisepticum, MIC ranges (µg/ml) by time period (no. of isolates) |
| Antimicrobial |
1975-1989 (175)
|
1990-2000 (66)
|
| Denagard® (tiamulin) |
0.0039-0.78
|
0.006-0.39
|
| Tylosin |
0.5
|
0.05-0.5
|
| Oxytetracycline |
0.5
|
0.1-0.5
|
| Lincomycin |
0.025
|
0.0025-50
|
| Enrofloxacin |
0.11
|
0.025->100
|
|
| Mycoplasma synoviae, MIC ranges (µg/ml) by time period (no. of isolates) |
| Antimicrobial |
1975-1989 (53)
|
1990-2000 (52)
|
| Denagard® (tiamulin) |
0.031-1.0
|
0.006-0.5
|
| Tylosin |
0.015-75
|
0.006-50
|
| Oxytetracycline |
0.06-0.08
|
0.025-100
|
| Lincomycin |
0.31-6.0
|
0.05-1.56
|
| Enrofloxacin |
0.1-1.0
|
0.025-1.56
|
|
| Mycoplasma meleagridis, MIC ranges (µg/ml) by time period (no. of isolates) |
| Antimicrobial |
1975-1989 (17)
|
1990-2000 (11)
|
| Denagard® (tiamulin) |
0.03-1.0
|
0.025-3.13
|
| Tylosin |
0.015-3.0
|
0.78-50
|
| Oxytetracycline |
0.3-5.0
|
0.05-25
|
| Lincomycin |
0.5-5.0
|
0.05-25
|
| Enrofloxacin |
0.015-1.0
|
0.1-3.13
|
|
| Mycoplasma iowae, MIC ranges (µg/ml) by time period (no. of isolates) |
| Antimicrobial |
1975-1989 (25)
|
1990-2000 (86)
|
| Denagard® (tiamulin) |
0.015-10
|
0.006-0.125
|
| Tylosin |
0.05-64
|
0.05-100
|
| Oxytetracycline |
1-3
|
0.025-100
|
| Lincomycin |
3-64
|
0.05-100
|
| Enrofloxacin |
0.1-1.0
|
0.005-1.0
|
|
MG has shown no resistance development to tiamulin over the last 25 years and all 241 isolates could be considered sensitive. In contrast there is resistance development to tylosin, oxytetracycline, lincomycin and borderline resistance to enrofloxacin and this appears to have increased in the last decade.
MS has shown no increase in resistance to tiamulin and almost all of the 105 isolates would be considered sensitive. In contrast, resistance has developed to tylosin and oxytetracycline. Levels of resistance to lincomycin remained low and all strains could be considered sensitive to enrofloxacin.
MM isolates (28) from turkeys showed some slight increase in resistance to tiamulin and enrofloxacin. However, tylosin, oxytetracycline and lincomycin showed a marked increase in resistance development.
MI has developed almost no resistance to tiamulin and enrofloxacin. In the nineties all isolates would be considered sensitive. High levels of resistance have developed to tylosin, oxytetracycline and lincomycin.
Denagard - your first choice for mycoplasma control in poultry
|